|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
INVITED REVIEW
Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia
The ability of the endothelium to produce nitric oxide is essential to maintenance of vascular homeostasis; disturbance of this ability is a major contributor to the pathogenesis of vascular disease. In vivo studies have demonstrated that expression of endothelial nitric oxide synthase (eNOS) is vital to endothelial function and have led to the understanding that eNOS expression is subject to modest but significant degrees of regulation. Subsequently, numerous physiological and pathophysiological stimuli have been identified that modulate eNOS expression via mechanisms that alter steady-state eNOS mRNA levels. These mechanisms involve changes in the rate of eNOS gene transcription (transcriptional regulation) and alteration of eNOS mRNA processing and stability (posttranscriptional regulation). In cultured endothelial cells, shear stress, transforming growth factor-
1, lysophosphatidylcholine, cell growth, oxidized linoleic acid, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, and hydrogen peroxide have been shown to increase eNOS expression. In contrast, tumor necrosis factor-
, hypoxia, lipopolysaccaride, thrombin, and oxidized LDL can decrease eNOS mRNA levels. For many of these stimuli, both transcriptional and posttranscriptional mechanisms contribute to regulation of eNOS expression. Recent studies have begun to further define signaling pathways responsible for changes in eNOS expression and have characterized cis- and trans-acting regulatory elements. In addition, a role has been identified for epigenetic control of eNOS mRNA levels. This review will discuss transcriptional and posttranscriptional regulation of eNOS with emphasis on the molecular mechanisms that have been identified for these processes.
gene regulation; mRNA stability; transcription; endothelium; 3'-untranslated region
This article has been cited by other articles:
![]() |
J. Li, A. Wilson, X. Gao, R. Kuruba, Y. Liu, S. Poloyac, B. Pitt, W. Xie, and S. Li Coordinated Regulation of Dimethylarginine Dimethylaminohydrolase-1 and Cationic Amino Acid Transporter-1 by Farnesoid X Receptor in Mouse Liver and Kidney and Its Implication in the Control of Blood Levels of Asymmetric Dimethylarginine J. Pharmacol. Exp. Ther., October 1, 2009; 331(1): 234 - 243. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Plock, N. Rafatmehr, D. Sinovcic, J. Schnider, H. Sakai, E. Tsuchida, A. Banic, and D. Erni Hemoglobin vesicles improve wound healing and tissue survival in critically ischemic skin in mice Am J Physiol Heart Circ Physiol, September 1, 2009; 297(3): H905 - H910. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Jones, M. B. Baker, M. Weber, D. G. Harrison, G. Bao, and C. D. Searles Molecular beacons can assess changes in expression and 3'-polyadenylation of human eNOS mRNA Am J Physiol Cell Physiol, March 1, 2009; 296(3): C498 - C504. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Yan, B. You, S.-P. Chen, J. K. Liao, and J. Sun Tumor Necrosis Factor-{alpha} Downregulates Endothelial Nitric Oxide Synthase mRNA Stability via Translation Elongation Factor 1-{alpha} 1 Circ. Res., September 12, 2008; 103(6): 591 - 597. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Wohlfart, H. Xu, A. Endlich, A. Habermeier, E. I. Closs, T. Hubschle, C. Mang, H. Strobel, T. Suzuki, H. Kleinert, et al. Antiatherosclerotic Effects of Small-Molecular-Weight Compounds Enhancing Endothelial Nitric-Oxide Synthase (eNOS) Expression and Preventing eNOS Uncoupling J. Pharmacol. Exp. Ther., May 1, 2008; 325(2): 370 - 379. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Wright and A. Churg Short-term exposure to cigarette smoke induces endothelial dysfunction in small intrapulmonary arteries: analysis using guinea pig precision cut lung slices J Appl Physiol, May 1, 2008; 104(5): 1462 - 1469. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kunieda, T. Minamino, K. Miura, T. Katsuno, K. Tateno, H. Miyauchi, S. Kaneko, C. A. Bradfield, G. A. FitzGerald, and I. Komuro Reduced Nitric Oxide Causes Age-Associated Impairment of Circadian Rhythmicity Circ. Res., March 14, 2008; 102(5): 607 - 614. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Li, A. Wilson, R. Kuruba, Q. Zhang, X. Gao, F. He, L.-M. Zhang, B. R. Pitt, W. Xie, and S. Li FXR-mediated regulation of eNOS expression in vascular endothelial cells Cardiovasc Res, January 1, 2008; 77(1): 169 - 177. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. V. Wang and P. E. Scherer Adiponectin, Cardiovascular Function, and Hypertension Hypertension, January 1, 2008; 51(1): 8 - 14. [Full Text] [PDF] |
||||
![]() |
I. Kosmidou, J. P. Moore, M. Weber, and C. D. Searles Statin Treatment and 3' Polyadenylation of eNOS mRNA Arterioscler Thromb Vasc Biol, December 1, 2007; 27(12): 2642 - 2649. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Yan, A. Huang, G. Kaley, and D. Sun Chronic high blood flow potentiates shear stress-induced release of NO in arteries of aged rats Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H3105 - H3110. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Geng, Y. Cui, J. Zhao, F. Yu, Y. Zhu, G. Xu, Z. Zhang, C. Tang, and J. Du Hydrogen sulfide downregulates the aortic L-arginine/nitric oxide pathway in rats Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2007; 293(4): R1608 - R1618. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mangat, S. Agarwal, and C. Rosendorff Do Statins Lower Blood Pressure? Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2007; 12(2): 112 - 123. [Abstract] [PDF] |
||||
![]() |
D. D. Kim, F. A. Sanchez, R. G. Duran, T. Kanetaka, and W. N. Duran Endothelial nitric oxide synthase is a molecular vascular target for the Chinese herb Danshen in hypertension Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2131 - H2137. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |